Titlebook: Advances in Radiation Oncology; Jeffrey Y.C. Wong,Timothy E. Schultheiss,Eric H. R Book 2017 Springer International Publishing AG 2017 Ima

euphoria

Combining Radiotherapy and Immunotherapy,e tumor control. We summarize the current knowledge of radiation therapy’s effects on the immune system, including results from preclinical and clinical trials, as well as future directions in combining radiotherapy and immunotherapy.

補(bǔ)充

SBRT and the Treatment of Oligometastatic Disease,th systemic therapy. In the past 20?years since the conception of the oligometastatic hypothesis, there have been advances in surgical and radiation therapy techniques resulting in reduced toxicities. Additionally, developments in systemic therapy have prolonged survival for patients with metastatic

傲慢物

MRI Guided Radiotherapy,nto the treatment room. Integrating MR with patient positioning and monitoring before and during treatment, respectively, would potentially improve radiation therapy treatment accuracy, enabling tighter uncertainty margins and ultimately improving outcomes. The challenges of integrating a MRI system

Gentry

Oncologic Applications of Magnetic Resonance Guided Focused Ultrasound,ding prostate, breast, gynecologic, gastrointestinal and brain cancers, and soft tissue tumors are in active development. This chapter provides an overview of MRgFUS including biological effects and physical parameters description. A comprehensive review of all currently approved and evolving oncolo

maroon

jaundiced

Biologic and Image Guided Systemic Radiotherapy,alogs or immunologically guided as in the case of radiolabeled antibodies directed against tumor associated antigens. Recent advances in intensity modulated radiation therapy allow for radiation dose sculpting to the entire body resulting in a more targeted form of total body irradiation, also refer

鳥(niǎo)籠

Cancer Stem Cells and Tumor Microenvironment in Radiotherapy,mplexity of the irradiated microenvironment. Such new knowledge provides the explanation for the long recognized tumor heterogeneity and tumor cell repopulation, one the major “R”s in tumor radiobiology, which involves cancer stem cells (also termed tumor-imitating cells, cancer stem-like cells, or

LAVE

Fsh238

Dirk J. Ruiter,Kees Welvaart,Soldano Ferroneth systemic therapy. In the past 20?years since the conception of the oligometastatic hypothesis, there have been advances in surgical and radiation therapy techniques resulting in reduced toxicities. Additionally, developments in systemic therapy have prolonged survival for patients with metastatic

洞穴